SCHEMBL17004423

SCHEMBL17004423

CC1(C)C2C=C(c3ccccc3CN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)cc4)CC3)C1(OC(=O)O)CC2

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 18/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2385278 0.91 BCL2 (0.59) BCL2
SCHEMBL2384588 0.91 BCL2 (0.59) BCL2
SCHEMBL2386142 0.90 BCL2 (0.58) BCL2
SCHEMBL2390421 0.88 BCL2 (0.56) BCL2
SCHEMBL2385928 0.88 BCL2 (0.56) BCL2
SCHEMBL2385244 0.87 BCL2 (0.55) BCL2
SCHEMBL2388882 0.85 BCL2 (0.53) BCL2
SCHEMBL2388682 0.83 BCL2 (0.51) BCL2
SCHEMBL2388689 0.83 BCL2 (0.51) BCL2
SCHEMBL19424633 0.83 BCL2 (0.50) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2550258-B1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE INC (US) 2015-08-19 — — EP claimed
Send feedback